{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:17:25Z","timestamp":1783102645376,"version":"3.54.6"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ARPA-H ADAPT","award":["140D042590013"],"award-info":[{"award-number":["140D042590013"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54 CA274502"],"award-info":[{"award-number":["U54 CA274502"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Cancer Cell Map Initiative","award":["U54 CA209891"],"award-info":[{"award-number":["U54 CA209891"]}]},{"name":"Cancer Biology, Informatics & Omics Training","award":["T32CA067754"],"award-info":[{"award-number":["T32CA067754"]}]},{"name":"Cancer Biology, Informatics & Omics Training","award":["K00 CA274649"],"award-info":[{"award-number":["K00 CA274649"]}]},{"name":"U.S. government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>Large pharmacogenomics screens have generated a wealth of information cataloguing the responses of more than a thousand tumor cell-line models to FDA-approved and exploratory drugs. Although centralized repositories have consolidated data access, the diversity of experimental platforms and response metrics used in these screens have made it challenging to integrate and compare their measured drug responses. Towards better pharmacogenomic data harmonization, we surveyed a range of data analysis protocols based on different curve-fitting functions (sigmoid, piecewise linear), different response metrics (IC50, EC50, integrated AUC), and different drug concentration windows (full range or truncated).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that an AUC derived from a sigmoidal curve fitted to a truncated dose range yields the strongest agreement between screening platforms, significantly bettering other protocols surveyed. This harmonization procedure also best aligns drug responses across successive iterations of the same platform. These findings broadly inform efforts to integrate drug response data in large-scale analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability<\/jats:title>\n                    <jats:p>The source code to generate drug response profiles and correlations are available at https:\/\/github.com\/digitaltumors\/Pharmacogenomics_Screens_Harmonization.git.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btag382","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:12:03Z","timestamp":1781320323000},"source":"Crossref","is-referenced-by-count":0,"title":["Harmonization and integration of pharmacogenomics screens"],"prefix":"10.1093","volume":"42","author":[{"given":"Aleysha T","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Bioengineering, University of California, San Diego , San Diego, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego , San Diego, CA 92093,","place":["United States"]},{"name":"Moores Cancer Center, University of California, San Diego , San Diego, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1708-8454","authenticated-orcid":false,"given":"Trey","family":"Ideker","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of California, San Diego , San Diego, CA 92093,","place":["United States"]},{"name":"Department of Medicine, University of California, San Diego , San Diego, CA 92093,","place":["United States"]},{"name":"Moores Cancer Center, University of California, San Diego , San Diego, CA 92093,","place":["United States"]},{"name":"Department of Computer Science and Engineering, University of California, San Diego , San Diego, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-3387","authenticated-orcid":false,"given":"Nicole M","family":"Mattson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego , San Diego, CA 92093,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026070313362355900_btag382-B1","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res"},{"key":"2026070313362355900_btag382-B2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B3","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1038\/nature20580","article-title":"Drug response consistency in CCLE and CGP","volume":"540","author":"Bouhaddou","year":"2016","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B4","doi-asserted-by":"crossref","first-page":"20180226","DOI":"10.1098\/rstb.2018.0226","article-title":"Applicability of drug response metrics for cancer studies using biomaterials","volume":"374","author":"Brooks","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2026070313362355900_btag382-B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/bjc.1991.16","article-title":"Chemosensitivity testing of small cell lung cancer using the MTT assay","volume":"63","author":"Campling","year":"1991","journal-title":"Br J Cancer"},{"key":"2026070313362355900_btag382-B6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature15736","article-title":"Pharmacogenomic agreement between two cancer cell line data sets","volume":"528","author":"Cancer Cell Line Encyclopedia Consortium and Genomics of Drug Sensitivity in Cancer Consortium","year":"2015","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B97399306","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03557-7","article-title":"Dual CDK and MEK inhibition potentiates CD8+ T cell-mediated antitumor immunity by inducing pyroptotic cell death in high-mutational head and neck cancer","volume":"44","author":"Chen","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"2026070313362355900_btag382-B7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s12885-017-3689-3","article-title":"GRcalculator: an online tool for calculating and mining dose-response data","volume":"17","author":"Clark","year":"2017","journal-title":"BMC Cancer"},{"key":"2026070313362355900_btag382-B8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat Cancer"},{"key":"2026070313362355900_btag382-B9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/01621459.1946.10501898","article-title":"The statistical sign test","volume":"41","author":"Dixon","year":"1946","journal-title":"J Am Stat Assoc"},{"key":"2026070313362355900_btag382-B10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1214\/088342304000000396","article-title":"Permutation methods: a basis for exact inference","volume":"19","author":"Ernst","year":"2004","journal-title":"Statist Sci"},{"key":"2026070313362355900_btag382-B11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","author":"Fallahi-Sichani","year":"2013","journal-title":"Nat Chem Biol"},{"key":"2026070313362355900_btag382-B12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature19838","article-title":"Consistency in large pharmacogenomic studies","volume":"540","author":"Geeleher","year":"2016","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B14","volume-title":"Springer Series in Statistics","author":"Good PI.","year":"2004"},{"key":"2026070313362355900_btag382-B15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1472-8206.2008.00633.x","article-title":"The Hill equation: a review of its capabilities in pharmacological modelling","volume":"22","author":"Goutelle","year":"2008","journal-title":"Fund Clin Pharmacol"},{"key":"2026070313362355900_btag382-B16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat Methods"},{"key":"2026070313362355900_btag382-B17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt.3882","article-title":"Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics","volume":"35","author":"Hafner","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2026070313362355900_btag382-B18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature12831","article-title":"Inconsistency in large pharmacogenomic studies","volume":"504","author":"Haibe-Kains","year":"2013","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2026070313362355900_btag382-B20","first-page":"17588359241287658","article-title":"Pharmacogenomics and big data in medical oncology: developments and challenges","volume":"16","author":"Marcu","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"2026070313362355900_btag382-B21","first-page":"G982","article-title":"Analysis and comparison of sigmoidal curves: application to dose-response data","volume":"257","author":"Meddings","year":"1989","journal-title":"Am J Physiol"},{"key":"2026070313362355900_btag382-B22","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1038\/nature20171","article-title":"Consistency in drug response profiling","volume":"540","author":"Mpindi","year":"2016","journal-title":"Nature"},{"key":"2026070313362355900_btag382-B23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s11033-025-10887-4","article-title":"Personalizing cancer therapy: the role of pharmacogenetics in overcoming drug resistance and toxicity","volume":"52","author":"Nafchi","year":"2025","journal-title":"Mol Biol Rep"},{"key":"2026070313362355900_btag382-B24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cels.2019.06.005","article-title":"A multi-center study on the reproducibility of drug-response assays in mammalian cell lines","volume":"9","author":"Niepel","year":"2019","journal-title":"Cell Syst"},{"key":"2026070313362355900_btag382-B25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/2159-8290.CD-13-0350","article-title":"Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia","volume":"3","author":"Pemovska","year":"2013","journal-title":"Cancer Discov"},{"key":"2026070313362355900_btag382-B26","author":"PNNL-CompBio\/coderdata: v2.1.0","year":"."},{"key":"2026070313362355900_btag382-B27","doi-asserted-by":"crossref","first-page":"51619","DOI":"10.18632\/oncotarget.10010","article-title":"Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies","volume":"7","author":"Pozdeyev","year":"2016","journal-title":"Oncotarget"},{"key":"2026070313362355900_btag382-B28","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.12688\/f1000research.9611.1","article-title":"Revisiting inconsistency in large pharmacogenomic studies","volume":"5","author":"Safikhani","year":"2016","journal-title":"F1000Res"},{"key":"2026070313362355900_btag382-B29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"key":"2026070313362355900_btag382-B30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/bioinformatics\/btv723","article-title":"PharmacoGx: an R package for analysis of large pharmacogenomic datasets","volume":"32","author":"Smirnov","year":"2016","journal-title":"Bioinformatics"},{"key":"2026070313362355900_btag382-B31","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab356","article-title":"A cross-study analysis of drug response prediction in cancer cell lines","volume":"23","author":"Xia","year":"2022","journal-title":"Brief Bioinform"},{"key":"2026070313362355900_btag382-B32","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies","volume":"4","author":"Yadav","year":"2014","journal-title":"Sci Rep"},{"key":"2026070313362355900_btag382-B33","doi-asserted-by":"crossref","first-page":"D1242","DOI":"10.1093\/nar\/gkac911","article-title":"CREAMMIST: an integrative probabilistic database for cancer drug response prediction","volume":"51","author":"Yingtaweesittikul","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026070313362355900_btag382-B34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nbt.3460","article-title":"High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines","volume":"34","author":"Yu","year":"2016","journal-title":"Nat Biotechnol"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btag382\/68520074\/btag382.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/42\/7\/btag382\/68520074\/btag382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/42\/7\/btag382\/68520074\/btag382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:36:50Z","timestamp":1783100210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btag382\/8707277"}},"subtitle":[],"editor":[{"given":"Christina","family":"Kendziorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btag382","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,12]]},"article-number":"btag382"}}